59th Annual Meeting of the Japanese Society of Neurology

Presentation information

Print

Evening Seminar

[ES-05] Novartis Pharma K.K

The position of L-dopa therapy in the new Parkinson's Disease clinical guideline

Fri. May 25, 2018 5:30 PM - 6:30 PM Room 8 (Royton Sapporo / Empress Hall （2F）)

Chair: Miho Murata(National Center of Neurology and Psychiatry Director General)

[ES-05-1] 新ガイドラインにおけるL-dopa治療の位置づけ

○Taku Hatano (Juntendo University Hospital Department of Neurology Associate Professor)